how much bpc 157 to take subcutaneous BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Best Way to Take BPC
Description
Lessons for Peptide Drug Development AOD-9604 highlights how promising biochemical logic can falter in translation from bench to bedside
They run a Western blot or ELISA test
doi:10.1016/j.archoralbio.2014.10.008
World Patent WO 2024/073762, 2 May 2024
